In clinical settings where laboratory infrastructure required for assessment of the value of urinary albumin excretion (UAE) is not available, which is the case in many primary healthcare settings, it is recommended to establish screening for diabetic nephropathy via semiquantitative dipstick measurement of albuminuria as an alternative and to receive follow-up care in the form of confirmatory diagnostic and clinical testing [7]. Here, ALB is linked to diabetic kidney disease.